Literature DB >> 19955248

Clinical pearls in thrombosis and anticoagulation.

Geno J Merli1, Scott C Litin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19955248      PMCID： PMC2787397          DOI： 10.4065/mcp.2009.0395

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  16 in total

1.  Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery.

Authors:  James D Douketis; Karen Woods; Gary A Foster; Mark A Crowther
Journal:  Thromb Haemost       Date:  2005-09       Impact factor: 5.249

Review 2.  Thrombolytic therapy in pregnancy.

Authors:  Georg Leonhardt; Charly Gaul; Hubert H Nietsch; Michael Buerke; Ekkehard Schleussner
Journal:  J Thromb Thrombolysis       Date:  2006-06       Impact factor: 2.300

3.  Comparison of fixed-dose weight-adjusted unfractionated heparin and low-molecular-weight heparin for acute treatment of venous thromboembolism.

Authors:  Clive Kearon; Jeffrey S Ginsberg; Jim A Julian; James Douketis; Susan Solymoss; Paul Ockelford; Sharon Jackson; Alexander G Turpie; Betsy MacKinnon; Jack Hirsh; Michael Gent
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

4.  Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.

Authors:  Annie M Young; Lucinda J Billingham; Gulnaz Begum; David J Kerr; Ana I Hughes; Daniel W Rea; Stephen Shepherd; Andrew Stanley; Ann Sweeney; Jonathan Wilde; Keith Wheatley
Journal:  Lancet       Date:  2009-02-14       Impact factor: 79.321

5.  Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin.

Authors:  Martin J O'Donnell; Clive Kearon; Judy Johnson; Marlene Robinson; Michelle Zondag; Irene Turpie; Alexander G Turpie
Journal:  Ann Intern Med       Date:  2007-02-06       Impact factor: 25.391

6.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

7.  Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Theodore E Warkentin; Andreas Greinacher; Andreas Koster; A Michael Lincoff
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

8.  The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  James D Douketis; Peter B Berger; Andrew S Dunn; Amir K Jaffer; Alex C Spyropoulos; Richard C Becker; Jack Ansell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

9.  Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Shannon M Bates; Ian A Greer; Ingrid Pabinger; Shoshanna Sofaer; Jack Hirsh
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

10.  Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Clive Kearon; Susan R Kahn; Giancarlo Agnelli; Samuel Goldhaber; Gary E Raskob; Anthony J Comerota
Journal:  Chest       Date:  2008-06       Impact factor: 9.410
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.